Status | Study |
RECRUITING |
Study Name: A Study of STAR-0215 in Participants With Hereditary Angioedema Condition: Hereditary Angioedema Date: 2023-01-06 Interventions: STAR-0215 will be administered as a subcutaneous bolus injection. |
Recruiting |
Study Name: Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema Condition: Hereditary Angioedema (HAE) Date: 2016-08-10 Interventions: Drug: BCX7353 Plasma kallikrei |
Active, not recruiting |
Study Name: Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE) Condition: Hereditary Angioedema (HAE) Date: 2016-08-09 Interventions: Drug: CINRYZE 500 U IV infusio |
Terminated |
Study Name: Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema Condition: Hereditary Angioedema HAE Date: 2016-01-20 Interventions: Drug: avoralstat Other Name: BCX4161 |
Active, not recruiting |
Study Name: Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema Condition: Hereditary Angioedema (HAE) Date: 2015-10-20 Interventions: Drug: C1 esterase inhibitor [human] liquid C1 Esterase Inhibitor [Human] Liquid administered Subcutaneou |
Active, not recruiting |
Study Name: A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2014-12-10 Interventions: Biological: C1-esterase inhibitor |
Completed |
Study Name: Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema (HAE) Subjects Condition: Hereditary Angioedema Date: 2014-03-17 Interventions: Drug: DX-2930 DX-2930 is a rec |
Active, not recruiting |
Study Name: Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema Condition: Hereditary Angioedema (HAE) Date: 2014-01-30 Interventions: Biological: CINRYZE 500 500 Un |
Completed |
Study Name: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2013-07-29 Interventions: Biological: Low-volume C1-esterase inhibitor |
Recruiting |
Study Name: Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2013-04-04 Interventions: Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc |